Skin  Cancer  Information



Aim at Melanoma (Aim for Answers, Action and the Cure
Key Melanoma Information Online
Article on Skin Cancers Rise, Along With Questionable Treatments
Melanoma and Advance Light Source Treatment Links
Melanoma Cancer Links
Melanoma International Foundation
Melanoma Patient's Information Page
Melanoma Research Foundation
Melanoma Resources
Melanoma... What is Melanoma
MetLife
        Skin Cancer Screening: What to Expect
Skin Cancer Identification
John Wayne Cancer Institute, Melanoma Program
KentuckyOne Health
        James Graham Brown Cancer Center
Memorial Sloan-Kettering Cancer Center
National Cancer Institute
The Ohio State University Comprehensive Cancer Center
        The James Cancer Hospital and Solove Research Institute
University of Texas
        M. D. Anderson Cancer Center Melanoma and Skin Center
University of Texas
        M. D. Anderson Cancer Center Melanoma Page
Common Skin Bacteria May Prevent Skin Cancer - February 28, 2018
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows - June 8, 2017
Deep Learning Algorithm Might Change How Skin Cancer Is Diagnosed - January 26, 2017
Treatment Blocking Melanoma Metastasis May Be on the Horizon - December 20, 2016
FDA Expands Nivoluimab"s Frontline Melanoma Approval to Include BRAF-Mutant Patients - January 23, 2016
Are We Winning the Fight Against Melanoma? - January 11, 2016
FDA Approves Vemurafenib and Cobimetinib Combination for Advanced Melanoma - November 11, 2015
FDA Approves Adjuvant Yervoy in Melanoma - October 28, 2015
FDA Approves Talimogene Laherparepvec (T-VEC) for Advanced Melanoma - October 27, 2015
FDA Approves Opdivo and Yervoy Combination for Advanced Melanoma - October 01, 2015
Bristol-Myers Drug Opdivo (Non - Chemo)- November 16, 2014
FDA Approval for Merck's Keytruda - September 4, 2014
Viral Cancer Vaccine Talimogene Laherparepvec (T-Vec) Tackles Melanoma Tumors - March 15, 2014
Lambrolizumab(MK-3475) Show Survival Benefit for Patients With Advanced Melanoma November 19, 2013
Versante (Innovative Systems for the Early Detection of Cancer)- November 12, 2013
FDA Approval for Yervoy (Ipilimumab) - July 3, 2013
FDA Approval for Vemurafenib (BRAF) - July 3, 2013
Drug Combination Against NRAS-Mutant Melanoma Discovered - September 17, 2012
2 New Drugs (Yervoy/Ipilimumab and Vemurafenib) to Treat Advanced Melanoma - June 6, 2011

Return to Main Page

If any of these links fail, please send me an email from the 'Main Page' and include the link that failed.